# Apollo Global Management, Inc.: overview

APO · NYSE · CIK 1858681 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/apo.md) · [Financials](/companies/apo/financials.md) · [Filings](/companies/apo/filings.md) · [Insiders](/companies/apo/insiders.md)

Latest reported revenue: [$11.15bn](/filings/0001858681-26-000040.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 10, 2026 (XBRL us-gaap:Revenues, accession 0001858681-26-000040).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [7.8](/filings/0001858681-25-000139.md) | [5.3 d](/filings/0001858681-26-000013.md) | [5.5](/filings/0001858681-26-000026.md) | [6.8](/filings/0001858681-26-000040.md) | [9.8](/filings/0001858681-25-000139.md) | [9.9 d](/filings/0001858681-26-000013.md) | [5.1](/filings/0001858681-26-000026.md) | [11.2](/filings/0001858681-26-000040.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [10.4%](/filings/0001858681-25-000139.md) | [28.1% d](/filings/0001858681-26-000013.md) | [8.0%](/filings/0001858681-26-000026.md) | [9.2%](/filings/0001858681-26-000040.md) | [17.7%](/filings/0001858681-25-000139.md) | [6.9% d](/filings/0001858681-26-000013.md) | [(37.7%)](/filings/0001858681-26-000026.md) | [12.2%](/filings/0001858681-26-000040.md) |
| Diluted EPS | $ per share | [1.29](/filings/0001858681-25-000139.md) | not reported | [0.68](/filings/0001858681-26-000026.md) | [0.99](/filings/0001858681-26-000040.md) | [2.78](/filings/0001858681-25-000139.md) | not reported | [(3.27)](/filings/0001858681-26-000026.md) | [2.15](/filings/0001858681-26-000040.md) |
| Free cash flow | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [6.0](/filings/0001858681-24-000031.md) | [11.0](/filings/0001858681-25-000034.md) | [32.6](/filings/0001858681-26-000013.md) | [26.1](/filings/0001858681-26-000013.md) | [32.0](/filings/0001858681-26-000013.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [30.9%](/filings/0001858681-24-000031.md) | [(17.9%)](/filings/0001858681-25-000034.md) | [15.5%](/filings/0001858681-26-000013.md) | [17.5%](/filings/0001858681-26-000013.md) | [10.9%](/filings/0001858681-26-000013.md) |
| Diluted EPS | $ per share | [7.32](/filings/0001858681-24-000031.md) | [(3.43)](/filings/0001858681-25-000034.md) | [8.28](/filings/0001858681-26-000013.md) | [7.33](/filings/0001858681-26-000013.md) | [5.54](/filings/0001858681-26-000013.md) |
| Free cash flow | $bn | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/apo/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $3.93bn | 33,224,455 |  | Reduced −1,317,482 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $3.34bn | 28,196,855 |  | Added +17,628 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $2.87bn | 24,220,604 |  | Added +2,244,146 |
| [Capital Research Global Investors](/funds/1422848.md) | 2026-06-30 | $2.84bn | 23,972,610 |  | Reduced −2,209,862 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $2.35bn | 19,878,764 |  | Added +260,464 |
| [Capital World Investors](/funds/1422849.md) | 2026-06-30 | $2.16bn | 18,279,251 |  | Reduced −628,311 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $1.72bn | 14,538,875 |  | Reduced −555,211 |
| [FRANKLIN RESOURCES INC](/funds/38777.md) | 2026-06-30 | $1.24bn | 10,456,470 |  | Added +579,111 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $1.22bn | 10,396,296 |  | Reduced −102,159 |
| [National Philanthropic Trust](/funds/1785342.md) | 2026-06-30 | $1.08bn | 9,138,579 |  | Added +133,266 |

## Recent filings

[All 745 filings](/companies/apo/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 09:05 ET | [8-K](/filings/0001858681-26-000059.md) | 7.01 Regulation FD disclosure | 0001858681-26-000059 |
| 2026-10-20 | 16:47 ET | [8-K](/filings/0000950142-26-002794.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950142-26-002794 |
| 2026-10-05 | 16:30 ET | [8-K](/filings/0001858681-26-000054.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001858681-26-000054 |
| 2026-09-21 | 07:36 ET | [8-K](/filings/0001858681-26-000051.md) | 7.01 Regulation FD disclosure | 0001858681-26-000051 |
| 2026-08-24 | 08:30 ET | [8-K](/filings/0001858681-26-000048.md) | 7.01 Regulation FD disclosure | 0001858681-26-000048 |
| 2026-08-14 | 16:33 ET | [SCHEDULE 13D](/filings/0000950142-26-002356.md) | Ownership report, active investor | 0000950142-26-002356 |
| 2026-08-13 | 07:03 ET | [8-K](/filings/0001858681-26-000046.md) | 7.01 Regulation FD disclosure | 0001858681-26-000046 |
| 2026-08-12 | 16:16 ET | [8-K/A](/filings/0000950142-26-002321.md) | 5.07 Shareholder vote results | 0000950142-26-002321 |
| 2026-08-11 | 08:35 ET | [8-K](/filings/0001858681-26-000043.md) | 7.01 Regulation FD disclosure | 0001858681-26-000043 |
| 2026-08-10 | 07:32 ET | [10-Q](/filings/0001858681-26-000040.md) | Quarterly report, period 2026-06-30 | 0001858681-26-000040 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001858681-26-000013.md), filed Feb 25, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1858681
- Tickers: APO, APOS
- Exchange: NYSE
- SIC code: 6282 Investment Advice
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 09:06 ET. No prices; not investment advice.